Old Web
English
Sign In
Acemap
>
Paper
>
IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Review of Clinical Efficacy, Safety, and Tolerability
IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Review of Clinical Efficacy, Safety, and Tolerability
2019
Sima Amin
Annika Silfvast-Kaiser
So Yeon Paek
Dario Kivelevitch
Alan Menter
Keywords:
moderate to severe
Tolerability
clinical efficacy
Interleukin 23
plaque psoriasis
Medicine
Dermatology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]